Guest guest Posted January 27, 2003 Report Share Posted January 27, 2003 Re: Fw: CIGUATERA In a message dated 1/26/03 1:48:31 PM Eastern Standard Time, melillo3@... writes: > DR. PEARN HAS WRITTEN DIRECTLY TO ME, THAT I COULD NOT HAVE > ANYTHING > RESEMBLING WHAT HE HAS RESEARCHED HIS ENTIRE LIFE. Dr. Pearn is not a researcher. He is an M.D. and he never did any testing. And I doubt that he understands that, although patients are highly positive to ciguatera, that may not necessarily mean that it is the exact same thing. That's what they're working on now as well as a lot of other things. And I don't think Dr. Pearn understands that this isn't acute poisoning but that it is being manufactured in the body. A lot of M.D.'s don't understand the research part of this but we're just following the science as that's the only thing that brings out the truth. There are some, dont get me wrong, that understand how important this discovery is. A few have even gotten in touch with us to congratulate us! Quote Link to comment Share on other sites More sharing options...
Guest guest Posted November 1, 2003 Report Share Posted November 1, 2003 oops, my last post was meant for another group. you can look more into this yourself though by going to Toxicology portion of this page: http://www.ncf-net.org/library/library.htm and reading about the ciguatoxin that shows up in 96% of CFSers and I think likely to show up in lymers too if they were tested. jason Quote Link to comment Share on other sites More sharing options...
Guest guest Posted March 16, 2004 Report Share Posted March 16, 2004 All I've been able to find is this website for the autistic unit at Sunderland Uni. http://osiris.sunderland.ac.uk/autism/hplc.htm BW, Sheila > RE: Re: ciguatera > > > That really sounds interesting - has it been published? > J & S <jim.sheila@...> wrote: > Thanks for all this, but if this ciguatera epitope is very similar to > ciguatera toxin how are we still functioning! > Recently I consulted Dr over here in UK who is finding, using dark > field microscopy " borrelia-like " spirochaetes in very large numbers of his > CFS patients (he is working in collaboration with a University and Dr Lida > Mattman and Dr Harvey from the US) > He is finding a common factor in 99.9% of these patients in a substance, > IAG, in the urine.This substance and it's precursors disrupt biological > membranes. Could this be the same thing as the ciguatera epitope > that he is > finding? Sorry if this is a really stupid question but it just struck me > that both disrupt cell membrane functioning? > This work on IAG is being done at Sunderland Uni by Prof Hooper at the > Autism Unit. > They find people with autism and that spectrum of conditions, GWS > patients, > CFS patients and people with organophosphate poisoning all have this > chemical, IAG, in their urine, that shouldn't be there. > In CFS this chemical is present in 99.9% of people, > In autism 88% > In families of autistic children 50% > In normal mortals 15% > > I asked Dr W what caused this IAG in the urine and he said they weren't > sure, could be genetic or environmental, infection or organophosphates or > combinations thereof. > IAG = trans-3(Indol-3-yl)Acriloglycine. It is an abnormal serotonin > metabolite, a product of disturbed tryptophan metabolism. > IAG increases membrane permiability so it increases gut and brain > permiability, affects hypothalmic functioning and " higher executive > functioning " and a negative effect on the immune system. > Could they be one and the same thing? > Whatever, this substance doesn't sound like a bundle of laughs to have > swimming around your body either. > BW, > Sheila > > > > --- Outgoing mail is certified Virus Free. Checked by AVG anti-virus system (http://www.grisoft.com). Version: 6.0.622 / Virus Database: 400 - Release Date: 13/03/04 Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.